Wednesday - September 2, 2026
Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling
August 18, 2026
NASHVILLE, Tennessee, Aug. 18 -- Vanderbilt University Medical Center posted the following news release:

* * *

Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling

*

Glucagon-like peptide 1 (GLP-1) receptor agonist drugs have been on the forefront as a promising treatment for multiple health issues -specifically in the management of type 2 diabetes and weight management.

Vanderbilt Health has opened en . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products